Vilya Stock / BioTech & PharmaFounded: 2022

Vilya is a computational biotechnology company that creates medicines designed to precisely target disease biology through a combination of machine-learning advancements and generative AI. Vilya was founded in 2022 and is headquartered in Seattle, WA. The company uses its proprietary technology platform to design novel molecular structures with drug-like properties, and it uses the information with the goal of creating therapeutic options for drug targets that are difficult to treat. Vilya’s approach seeks to overcome the limitations of traditional drug discovery methods that rely on random screening tactics.

Register To Buy and Sell Shares

For more details on financing and valuation for Vilya, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Vilya’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Vilya.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.


Management Team

Cyrus Harmon Ph.D
Chief Executive Officer & President
Katerina Leftheris Ph.D
Chief Scientific Officer
Patrick Salveson Ph.D
Co-Founder & Chief Technology Officer
Inca Dieterich Ph.D
Co-Founder & Vice President, Business Development
Adam Moyer Ph.D
Co-Founder & Director of Design Research
Nao Hiranuma Ph.D
Co-Founder & Director of Machine Learning
Brian Hearn Ph.D
Vice President, Chemistry
Ben Sellers Ph.D
Vice President, Computational Chemistry
David Kulp Ph.D
Vice President, Informatics
Daniel Wright
Senior Director of Operations

Board Members

Greg Yap
Menlo Ventures

Vilya’s stock FAQs


Can you buy Vilya’s stock?

Vilya is not publicly traded on NYSE or NASDAQ in the U.S. To buy Vilya’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Can you sell Vilya’s stock?

Yes, you can sell stock of a private company like Vilya. Forge can help you sell your Vilya stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.

What is Vilya’s stock price?

Vilya is a privately held company and therefore does not have a public stock price. However, you may access Vilya’s private market stock price with Forge Data.

What is Vilya’s stock ticker symbol?

Vilya does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Vilya Expands Series A Financing to $71M

In a series A funding round led by ARCH Venture Partners, Vilya raised $71 million.
Updated on: Jun 25, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.